ANIP Forecast and Technical Stock Analysis
Sell candidate since 2019-08-07 Loss -7.00%
ANI Pharmaceuticals fell by -1.46% in the last day ( Monday, 19th Aug 2019 ) from $68.54 to $67.54 During the day the stock fluctuated 2.43% from a day low at $67.41 to a day high of $69.05. The price has fallen in 6 of the last 10 days and is down by -18.17% for this period. Volume has increased in the last day by 47 406 shares but on falling prices. This may be an early warning and the risk will be increased slightly for the next couple of days. In total, 208 545 shares bought and sold for approximately $14.09 million.
- 30 day high of the ANIP stock price was $86.96 and low was $63.73.
- 90 day high was $86.96 and low was $63.73.
- 52 week high for ANI Pharmaceuticals - $86.96 and low - $36.92.
ANI Pharmaceuticals lies in the lower part of a very wide and strong rising trend in the short term, and this will normally pose a very good buying opportunity. A break down the bottom trend line at $67.38 will firstly indicate a slower raising rate, but may also be a early warning for a trend shift. Given the current short-term trend, the stock is expected to rise 11.37% during the next 3 months and, with 90% probability hold a price between $75.04 and $98.77 at the end of this period.
A buy signal was issued from a pivot bottom point on Thursday August 15, 2019, which indicates further gains until a new top pivot has been found. Some negative signals were issued as well, and these may have some influence on the near short-term development. ANI Pharmaceuticals holds sales signals from both short- and long-term moving averages. In addition, there is a general sales signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up there will be some resistance from the lines at $69.76 and $79.46. A break-up above any of these levels will issue buy signals. Volume rose on falling prices yesterday. This may be an early warning and the stock should be followed more closely.
Relative Strength Index (RSI)
RSImin/max Values: [ 25 - 75 ]
RSI14 is 13 and the stock is extremely oversold on RSI14, but some stocks may continue to fall despite the high chance of a correction up. The low RSI lowers the general risk and the stock should be considered if other technical requirements like liquidity and risk-reward are meet.
* Stockinvest.us uses dynamical calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behaviour.
Support & Resistance
ANI Pharmaceuticals finds support from accumulated volume at $67.09.
This stock may move much during a day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $1.64 between high and low, or 2.43%. For the last week, the stock has had a daily average volatility of 4.45%.
ANI Pharmaceuticals is oversold on RSI14 (13). Some stocks may fall long and hard while being oversold on RSI, but stocks that are heavily oversold on RSI often pose good re-bounce chance and played well it can be a buying opportunity.
Our recommended stop-loss: We hold a sell evaluation for this stock. No stop-loss set.
4.45 %Average volatility
Very Low Low Medium High Very High
|ANIP $67.54 ($-1.00 -1.46%)|
ANIP is down $1.00 today, but where's it headed in 2019?
|Zacks Investment Research is releasing its prediction for ANIP based on the 1-3 month system that more than doubles the S&P 500.
This report is free today for StockInvest.us readers.
Click here – the ANIP analysis is free »
Golden Star Signal
This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.
This signal is rare and, in most cases, gives substantial returns. From 8.000 stocks usually only a few will trigger a Golden Star Signal per day!